These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 25808853)
1. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells. Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853 [TBL] [Abstract][Full Text] [Related]
2. Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells. Cai L; Wang D; Fisher AL; Wang Z Biochem Biophys Res Commun; 2014 May; 447(2):292-8. PubMed ID: 24727455 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis. Jin HJ; Zhao JC; Ogden I; Bergan RC; Yu J Cancer Res; 2013 Jun; 73(12):3725-36. PubMed ID: 23539448 [TBL] [Abstract][Full Text] [Related]
4. Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia. Grabowska MM; Kelly SM; Reese AL; Cates JM; Case TC; Zhang J; DeGraff DJ; Strand DW; Miller NL; Clark PE; Hayward SW; Gronostajski RM; Anderson PD; Matusik RJ Endocrinology; 2016 Mar; 157(3):1094-109. PubMed ID: 26677878 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells. Krause WC; Shafi AA; Nakka M; Weigel NL Int J Biochem Cell Biol; 2014 Sep; 54():49-59. PubMed ID: 25008967 [TBL] [Abstract][Full Text] [Related]
6. FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer. Jones D; Wade M; Nakjang S; Chaytor L; Grey J; Robson CN; Gaughan L Oncotarget; 2015 Oct; 6(30):29782-94. PubMed ID: 26336819 [TBL] [Abstract][Full Text] [Related]
7. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner. Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451 [TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. Takayama K; Suzuki T; Tsutsumi S; Fujimura T; Takahashi S; Homma Y; Urano T; Aburatani H; Inoue S Mol Endocrinol; 2014 Dec; 28(12):2012-24. PubMed ID: 25329375 [TBL] [Abstract][Full Text] [Related]
10. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer. Qiu M; Bao W; Wang J; Yang T; He X; Liao Y; Wan X BMC Cancer; 2014 Feb; 14():78. PubMed ID: 24512546 [TBL] [Abstract][Full Text] [Related]
11. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer. Pascal LE; Wang Y; Zhong M; Wang D; Chakka AB; Yang Z; Li F; Song Q; Rigatti LH; Chaparala S; Chandran U; Parwani AV; Wang Z Neoplasia; 2018 Apr; 20(4):351-363. PubMed ID: 29518696 [TBL] [Abstract][Full Text] [Related]
12. Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cells. Yang T; Jing Y; Dong J; Yu X; Zhong M; Pascal LE; Wang D; Zhang Z; Qiao B; Wang Z Prostate; 2018 Nov; 78(15):1201-1212. PubMed ID: 30009504 [TBL] [Abstract][Full Text] [Related]
13. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells. Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046 [TBL] [Abstract][Full Text] [Related]
15. Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells. Qiao Z; Wang D; Hahn J; Ai J; Wang Z Prostate; 2014 Feb; 74(2):113-20. PubMed ID: 24272884 [TBL] [Abstract][Full Text] [Related]
16. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway. Imamura Y; Sakamoto S; Endo T; Utsumi T; Fuse M; Suyama T; Kawamura K; Imamoto T; Yano K; Uzawa K; Nihei N; Suzuki H; Mizokami A; Ueda T; Seki N; Tanzawa H; Ichikawa T PLoS One; 2012; 7(8):e42456. PubMed ID: 22879989 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain. Hahn J; Xiao W; Jiang F; Simone F; Thirman MJ; Wang Z Prostate; 2007 Feb; 67(2):146-53. PubMed ID: 17044034 [TBL] [Abstract][Full Text] [Related]
18. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
20. FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer. Gerhardt J; Montani M; Wild P; Beer M; Huber F; Hermanns T; Müntener M; Kristiansen G Am J Pathol; 2012 Feb; 180(2):848-61. PubMed ID: 22138582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]